Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Montelukast as a Controller of Atopic Syndrome

NCT00559546 is registered in ClinicalTrials.gov with University of Helsinki as lead sponsor.

NCT NCT00559546
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00559546 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Montelukast as a Controller of Atopic Syndrome
Lead sponsor
University of Helsinki
Phase
Phase 4
Overall status
Completed
Start date
March 31, 2007
Completion date
July 31, 2007
Enrollment
61 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

allergic conjunctivitis, asthma, atopic eczema, seasonal allergic rhinitis